Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the USA / NCT05046600
Recruiting Observational

Registry of Arthrex Hand and Wrist Products

NCT05046600 · tracked via the Priya Life Science USA tracker
Sponsor
Arthrex, Inc
Phase
Observational
Started
2021-07-20
Last updated
2025-06-26

Condition(s) studied

Ulnar/Radial Collateral Ligament ReconstructionLigament Repair or ReconstructionSmall Bone Fragments and ArthrodesisScapholunate Ligament ReconstructionCarpal Fusion (Arthrodesis) of the HandDigital Tendon TransfersCarpometacarpal Joint ArthroplastyArthrodesisDigital Tendon TransferDistal Radius Fracture Fixation

Investigational drug(s) / intervention(s)

Products listed in cohort description

Products listed in cohort description: Depending on approved indication per product

Study summary

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Subject requires surgery using Arthrex hand and wrist implants included in the registry. 2. Subject is 18 years of age or over. 3. Subject is not considered a vulnerable subject (i.e. child, pregnant, nursing, prisoner, or ward of the state). 4. Subject signed informed consent and is willing and able to comply with all registry requirements Exclusion Criteria: 1. Insufficient quantity or quality of bone. 2. Blood supply limitations and previous infections, which may retard healing. 3. Foreign-body sensitivity or foreign-body reactions. 4. Any active infection or blood supply limitations. 5. Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period. 6. Subjects that are skeletally immature -

Primary outcome measure(s)

  • To assess a change in Visual Analogue Scale (VAS) survey — Preoperatively, 3 months, 6 months and 12 months postoperatively
    Patient reported pain scale 0-10 point scale (0 min,10 max)

Trial sites (5)

FacilityCityRegionStatus
MORE Foundation Phoenix Arizona Recruiting
Banner Health Tuscon Arizona Recruiting
University of Iowa Iowa City Iowa Terminated
Duke University Durham North Carolina Recruiting
West Virginia University Morgantown West Virginia Recruiting

More Arthrex, Inc. trials in the USA

Knee Related Subchondral Bone Lesions Treated With IOBP Recruiting
Evaluate the Continued Safety and Performance of the Foot and Ankle Products Recruiting
Total Shoulder Arthroplasty Multi-Center Registry Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05046600 on ClinicalTrials.gov ↗ ← All trials in the USA